These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 20271603)

  • 1. Effect of intravenous administration of dextran, a macromolecular carbohydrate, in animals.
    GOLDENBERG M; CRANE RD; POPPER H
    Am J Clin Pathol; 1947 Dec; 17(12):939-48. PubMed ID: 20271603
    [No Abstract]   [Full Text] [Related]  

  • 2. [Prolonged coagulation time following intravenous administration of 6% dextran solution].
    MOLKE W
    Pol Tyg Lek (Wars); 1956 Aug; 11(33):1462-3. PubMed ID: 13388821
    [No Abstract]   [Full Text] [Related]  

  • 3. Effects of intravenous administration of dextran on renal function.
    FLEMING JW; CARGILL WH; BLOOM WL
    Proc Soc Exp Biol Med; 1952 Apr; 79(4):604-6. PubMed ID: 14920509
    [No Abstract]   [Full Text] [Related]  

  • 4. The carbohydrate content of the gastric juice after intravenous administration of partly hydrolysed, bacterial dextran to hospital cases.
    TROELL L; ABERG B
    Scand J Clin Lab Invest; 1952; 4(4):355-8. PubMed ID: 13048617
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessment of Dextran Antigenicity of Intravenous Iron Preparations with Enzyme-Linked Immunosorbent Assay (ELISA).
    Neiser S; Koskenkorva TS; Schwarz K; Wilhelm M; Burckhardt S
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27455240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevention of indium intoxication by ferric dextran.
    GABBIANI G; SELYE H; TUCHWEBER B
    Br J Pharmacol Chemother; 1962 Dec; 19(3):508-12. PubMed ID: 13945982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the occurrence of dextran in the gastrointestinal tract after intravenous infusion of dextran solutions (Macrodex).
    GRONWALL A; WILKSTROM K
    Acta Soc Med Ups; 1953 Dec; 59(1-2):24-32. PubMed ID: 13138317
    [No Abstract]   [Full Text] [Related]  

  • 8. [Maintenance of intravenous dextran in blood & urine].
    DAROCHA T; KOSTRZEWSKA E
    Pol Tyg Lek (Wars); 1959 Mar; 14(12):549-53. PubMed ID: 13667625
    [No Abstract]   [Full Text] [Related]  

  • 9. REACTIONS TO TOTAL DOSE INTRAVENOUS INFUSION OF IRON DEXTRAN (IMFERON).
    CLAY B; ROSENBERG B; SAMPSON N; SAMUELS SI
    Br Med J; 1965 Jan; 1(5426):29-31. PubMed ID: 14213099
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular composition of dextran solutions for intravenous use.
    RICKETTS CR; LORENZ L; MAYCOCK Wd
    Nature; 1950 May; 165(4202):770-1. PubMed ID: 15416851
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of the intravenous administration of dextran on cardiac output and other circulatory dynamics.
    WITHAM AC; FLEMING JW; BLOOM WL
    J Clin Invest; 1951 Sep; 30(9):897-902. PubMed ID: 14880616
    [No Abstract]   [Full Text] [Related]  

  • 12. Further studies of a hemostatic defect caused by intravenous dextran.
    ADELSON E; CROSBY WH; ROEDER WH
    J Lab Clin Med; 1955 Mar; 45(3):441-8. PubMed ID: 14354329
    [No Abstract]   [Full Text] [Related]  

  • 13. The effect of intravenous infusion of large quantities of dextran solution on kidney function in man.
    BERGSTROM J; BUCHT H; EK J; JOSEPHSON B; WERKO L
    Scand J Clin Lab Invest; 1959; 11():82-96. PubMed ID: 13646605
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrotic edema treated with intravenous infusions of concentrated dextran and protein solutions.
    FJELDBORG N; BASTRUP-MADSEN P; SONDERGAARD G
    Acta Med Scand; 1955 Jul; 152(1):39-45. PubMed ID: 13248465
    [No Abstract]   [Full Text] [Related]  

  • 15. [TREATMENT OF BLOOD CIRCULATION DISTURBANCES BY MEANS OF CONTINUOUS INTRAVENOUS INFUSION OF RHEOMACRODEX 10 PER CENT].
    LOESEL H
    Med Klin; 1964 Sep; 59():1433-8. PubMed ID: 14315270
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacokinetics of low molecular (monovalent) dextran (Dx 1) in volunteers.
    Schwarz JA; Koch W; Bühler V; Kaumeier S
    Int J Clin Pharmacol Ther Toxicol; 1981 Aug; 19(8):358-67. PubMed ID: 6171533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [ON THE TECHNIC OF DETERMINING THE VOLUME OF CIRCULATING BLOOD WITH THE USE OF POLYGLUCIN].
    BARBINOV VA
    Lab Delo; 1964; 10():421-3. PubMed ID: 14258532
    [No Abstract]   [Full Text] [Related]  

  • 18. [Intravenous infusion of poliglukan following hemorrhagic shock in animals].
    DUBROWSKI J; PANASEWICZ J
    Acta Physiol Pol; 1953; 4(4):283-96. PubMed ID: 13138269
    [No Abstract]   [Full Text] [Related]  

  • 19. Morphologic changes in rabbits following the intravenous administration of meningococcal toxin. III. The effects produced by endotoxin in association with certain high molecular weight acidic polymers.
    BRUNSON JG; DAVIS RL; THOMAS L
    Am J Pathol; 1955; 31(4):669-85. PubMed ID: 14388126
    [No Abstract]   [Full Text] [Related]  

  • 20. Uptake of fluorescein isothiocyanate-labelled dextran into the CSF after intranasal and intravenous administration to rats.
    in 't Veen JP; van den Berg MP; Romeijn SG; Verhoef JC; Merkus FW
    Eur J Pharm Biopharm; 2005 Sep; 61(1-2):27-31. PubMed ID: 15893918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.